Trade trend analysis
Number of Transactions
Quantity
Weight
Number of Transactions
Quantity
Weight
The above chart presents the market trend analysis for pulse pharma from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 4 transactions, with a transaction quantity of 19750 and a transaction weight of 0.
-
2025
62
271979
0
-
2026
4
19750
0
Bill of lading data
<
1/15
>
Products
Total 57
-
vitamin b
21
16.15%
>
-
sucralose
17
13.08%
>
-
ascorbic acid
15
11.54%
>
-
pyridoxine hydrochloride
12
9.23%
>
-
sorbic acid
8
6.15%
>
+View All
Hscode rank
Total 57
-
HS 29321400
24
18.46%
>
-
HS 29362700
15
11.54%
>
-
HS 29362500
13
10%
>
-
HS 29362400
11
8.46%
>
-
HS 29061990
10
7.69%
>
+View All
Port statistics
Total 31
-
nhava sheva sea innsa1
230
18.08%
>
-
sahar air cargo acc inbom4
137
10.77%
>
-
nhava sheva
93
7.31%
>
-
nhavasheva innsa1
61
4.80%
>
-
jnpt
58
4.56%
>
+View All
pulse pharma is india Buyer&Supplier,
and primarily engages in the import and export business of products such as vitamin b,sucralose,ascorbic acid.
According to the 52wmb.com global trade database, as of 2026-02-24, the company has completed 1272 international trades,
The core products include HS29321400,HS29362700,HS29362500 etc,
often transported via nhava sheva sea innsa1,port sahar air cargo acc inbom4, port nhava sheva etc,
and its main trading partners are dsm nutritional products asia pacif,basf south east asia pte ltd.co,basf hong kong ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on pulse pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.